Default company panoramic image
62fc61a2 0c75 4a38 a380 460c821ee9e4

MimiVax LLC

MimiVax is a biotech startup with exclusive license to commercialize SurVaxM, a new vaccine to treat cancer.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Buffalo, NY, USA
  • Currency USD
  • Website mimivax.com

Company Summary

Team

  • Default avatar
    Robert Fenstermaker
    Co-Founder and CMO
    Unconfirmed

  • Default avatar
    Michael Ciesielski
    Co-Founder and CSO
    Unconfirmed

  • Default avatar
    Scott Friedman
    Co-Founder
    Unconfirmed

Advisors

  • Default avatar
    Scott Friedman, Esq
    Lawyer
    Unconfirmed
    Default avatar
    Michael Songin
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    All funding to date has been from non-dilutive grant support
    Unconfirmed